On the one hand, the activation of H1R and H3R in the differentiation process of DCs leads to positive stimulation of the tumor-related antigen-presentation capacity, the production of pro-inflammatory cytokines (IL-12, IFN-γ), and TH1 polarization [71,72]. The gene discussed is HRH1; the disease is neoplasm.